FRESCO-2 Trial Meets Endpoints: Metastatic Colorectal Cancer Colorectal 15 Mins Read3 FRESCO-2 Trial Met Primary Endpoints in Patients With Metastatic Colorectal announced HUTCHMED from the Fruquintinib Global Phase III Trial The…
